SCHEMBL8200714

SCHEMBL8200714

CCOC(=O)CC(=O)CC1NCCc2cc(OC)c(OC)cc21

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
BCHE P06276 1/20 0.51
GRIN2D O15399 8/20 0.47
GRIN3B O60391 8/20 0.47
GRIN1 Q05586 8/20 0.47
GRIN2A Q12879 8/20 0.47
GRIN2B Q13224 8/20 0.47
GRIN2C Q14957 8/20 0.47
GRIN3A Q8TCU5 8/20 0.47
MEN1 O00255 1/20 0.47
MAPK1 P28482 1/20 0.47
CASP1 P29466 1/20 0.47
TSHR P16473 1/20 0.47
MAOA P21397 1/20 0.47
KDM4C Q9H3R0 1/20 0.47
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL422740 0.99 KMT2A (0.57) KMT2ABCHEGRIN2DGRIN3BGRIN1
SCHEMBL3383043 0.91 KMT2A (0.62) KMT2ABCHEGRIN2DGRIN3BGRIN1
SCHEMBL8202805 0.91 BCHE (0.55) KMT2ABCHEGRIN2DGRIN3BGRIN1
SCHEMBL3382275 0.91 KMT2A (0.62) KMT2ABCHEGRIN2DGRIN3BGRIN1
Hydrochloric Acid SCHEMBL420910 0.90 BCHE (0.54) KMT2ABCHEGRIN2DGRIN3BGRIN1
SCHEMBL10044164 0.87 KMT2A (0.43) KMT2ABCHEKDM4EGAAMAPT
SCHEMBL14266747 0.85 BCHE (0.50) KMT2ABCHEGRIN2DGRIN3BGRIN1
Hydrochloric Acid SCHEMBL423191 0.84 BCHE (0.49) KMT2ABCHEGRIN2DGRIN3BGRIN1
Hydrochloric Acid SCHEMBL6478440 0.83 BCHE (0.57) KMT2ABCHEGRIN2DGRIN3BGRIN1
SCHEMBL10072024 0.81 BCHE (0.55) KMT2ABCHEGRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150252039-A1 Process For The Preparation Of Pyrido[2,1-a] Isoquinoline Derivatives By Catalytic Asymmetric Hydrogenation Of An Enamine HOFFMANN-LA ROCHE INC. 2015-09-10 US disclosed
US-20150126743-A1 Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine HOFFMANN-LA ROCHE INC. 2015-05-07 US disclosed
US-20150031888-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2015-01-29 US disclosed
US-20140187785-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE HOFFMANN-LA ROCHE INC. (US) 2014-07-03 US disclosed
US-20130109859-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE HOFFMANN-LA ROCHE INC. (US) 2013-05-02 US disclosed
US-20120022260-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE ABRECHT STEFAN (CH) 2012-01-26 US disclosed
EP-2066667-B1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE HOFFMANN LA ROCHE (CH) 2011-08-31 EP disclosed
US-20080076925-A1 PROCESS FOR THE PREPARATION OF PYRIDO [ 2-1-A] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 US disclosed
US-20080076925-A1 PROCESS FOR THE PREPARATION OF PYRIDO [ 2-1-A] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 US disclosed
WO-2008031749-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-20 WO disclosed
US-20080071087-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE HOFFMAN-LA ROCHE INC. 2008-03-20 US disclosed
US-20080071087-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE HOFFMAN-LA ROCHE INC. 2008-03-20 US disclosed
WO-2008031750-A2 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076925-A1 PROCESS FOR THE PREPARATION OF PYRIDO [ 2-1-A] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE PNISR, SFPQ, PLPBP KMT2A 577/4885BCHE 2252/4885GRIN2D 920/4885
US-20130109859-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 KMT2A 819/4885BCHE 1450/4885GRIN2D 791/4885
US-20150031888-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 KMT2A 819/4885BCHE 1450/4885GRIN2D 791/4885
US-20120022260-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE PNPO, ENO1, CHRM1 KMT2A 2002/4885BCHE 1011/4885GRIN2D 1255/4885
US-20150252039-A1 Process For The Preparation Of Pyrido[2,1-a] Isoquinoline Derivatives By Catalytic Asymmetric Hydrogenation Of An Enamine IDO2, IDO1, H1-2 KMT2A 819/4885BCHE 1450/4885GRIN2D 791/4885
US-20150126743-A1 Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine PNPO, ENO1, CHRM1 KMT2A 2002/4885BCHE 1011/4885GRIN2D 1255/4885
US-20140187785-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 KMT2A 819/4885BCHE 1450/4885GRIN2D 791/4885
US-20080071087-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE PNPO, ENO1, CHRM1 KMT2A 2002/4885BCHE 1011/4885GRIN2D 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.